Inhibition of Mammalian Glycan Biosynthesis Produces Non-self Antigens for a Broadly Neutralising, HIV-1 Specific Antibody
Authors:
- Christopher N. ScanlanCSChristopher N. Scanlan
- Gayle E. RitchieGRGayle E. Ritchie
- Kavitha BaruahKBKavitha Baruah
- Max CrispinMCMax Crispin
- David J. HarveyDHDavid J. Harvey
- Bernhard B. SingerBSBernhard B. Singer
- Lothar LuckaLLLothar Lucka
- Mark R. WormaldMWMark R. Wormald
- Paul WentworthPWPaul Wentworth
- Nicole ZitzmannNZNicole Zitzmann
- Pauline M. RuddPRPauline M. Rudd
- Dennis R. BurtonDBDennis R. Burton
- 1 September 2007
- journal article
- research article
- Published by Elsevier in Journal of Molecular Biology
- Vol. 372 (1) , 16-22
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Structural definition of a conserved neutralization epitope on HIV-1 gp120Nature, 2007
- Neutralizing Antibody Responses against Autologous and Heterologous Viruses in Acute versus Chronic Human Immunodeficiency Virus (HIV) Infection: Evidence for a Constraint on the Ability of HIV To Completely Evade Neutralizing Antibody ResponsesJournal of Virology, 2006
- GP120: Target for Neutralizing HIV-1 AntibodiesAnnual Review of Immunology, 2006
- Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infectionProceedings of the National Academy of Sciences, 2005
- Antibody vs. HIV in a clash of evolutionary titansProceedings of the National Academy of Sciences, 2005
- Comprehensive Cross-Clade Neutralization Analysis of a Panel of Anti-Human Immunodeficiency Virus Type 1 Monoclonal AntibodiesJournal of Virology, 2004
- Antibody Domain Exchange Is an Immunological Solution to Carbohydrate Cluster RecognitionScience, 2003
- Antibody neutralization and escape by HIV-1Nature, 2003
- Broadly Neutralizing Antibodies Targeted to the Membrane-Proximal External Region of Human Immunodeficiency Virus Type 1 Glycoprotein gp41Journal of Virology, 2001
- Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine designImmunology Letters, 1997